MeiraGTx Holdings plc Ordinary Shares (NASDAQ: MGTX) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT MEIRAGTX HOLDINGS PLC ORDINARY SHARES

MeiraGTx Holdings plc Ordinary Shares (NASDAQ: MGTX)
Listen to this Section


$6.74
+0.4190 ( +5.96% ) 138.9K

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Market Data


Open $6.74
Previous Close $6.32
Volume 138.9K
Market Cap $499.40M
Day Range $6.32 - $6.79
52 Week Range $3.85 - $7.37
Shares Outstanding 78.15M
Change % +5.96%
Net Change ▲ 0.4190
Insider Ownership 0.10%
Exchange NASDAQ
Sector Miscellaneous
Industry None
IPO Year 2018
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -6,206,814.00

Date Type Amount Purchased Purchaser
2024-08-14 Buy 1250000.00 PERCEPTIVE ADVISORS LLC
2024-06-07 Sale -45000.00 PERCEPTIVE ADVISORS LLC
2024-06-06 Sale -30000.00 Harris Keith R.
2024-06-06 Sale -45000.00 Mendoza Neil
2024-06-06 Sale -45000.00 Hukkelhoven Ellen
2024-06-06 Sale -45000.00 SHENK THOMAS E
2024-06-06 Sale -45000.00 Seligman Nicole
2024-06-06 Sale -45000.00 Yu Debra
2024-06-06 Sale -20000.00 Indyk Martin
2024-05-30 Sale -3000.00 Giroux Richard

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jan 16, 2025
4 Insider transactions 1 Jan 16, 2025
4 Insider transactions 1 Jan 16, 2025
4 Insider transactions 1 Jan 16, 2025
4 Insider transactions 1 Jan 10, 2025
4 Insider transactions 1 Jan 10, 2025
4 Insider transactions 1 Jan 10, 2025
4 Insider transactions 1 Jan 10, 2025
4 Insider transactions 1 Jan 10, 2025
8-k 8K-related 15 Dec 09, 2024

Latest News


× Before browsing our site, please accept our cookies policy